Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Bianca Backx"'
Autor:
Francesco, Costa, Salvatore, Brugaletta, Alberto, Pernigotti, Eduardo, Flores-Ulmanzor, Luis, Ortega-Paz, Angel, Cequier, Andres, Iniguez, Antoni, Serra, Pilar, Jiménez-Quevedo, Vicente, Mainar, Gianluca, Campo, Maurizio, Tespili, Peter, den Heijer, Armando, Bethencourt, Nicolás, Vazquez, Gerrit Anne, van Es, Bianca, Backx, Marco, Valgimigli, Patrick, Serruys, Manel, Sabaté
Publikováno v:
Circulation. Cardiovascular interventions. 12(9)
Drug-eluting stents (DES) showed improved efficacy and safety compared with bare-metal stents (BMS), and international guidelines recommend their use as first line treatment. Yet, BMS are still widely used in practice, especially in large coronary ve
Autor:
Andrés Iñiguez, Patrick W. Serruys, Luis Ortega-Paz, Gianluca Campo, Salvatore Brugaletta, Gerrit Anne van Es, Vicente Mainar, Eduardo Flores-Ulmanzor, Armando Bethencourt, Antoni Serra, Nicolás Vázquez, Marco Valgimigli, Maurizio Tespili, Francesco Costa, Alberto Pernigotti, Bianca Backx, Peter den Heijer, Pilar Jiménez-Quevedo, Manel Sabaté, Angel Cequier
Publikováno v:
Circulation-Cardiovascular Interventions
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
CIRCULATION-CARDIOVASCULAR INTERVENTIONS
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Consejo Superior de Investigaciones Científicas (CSIC)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
CIRCULATION-CARDIOVASCULAR INTERVENTIONS
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Consejo Superior de Investigaciones Científicas (CSIC)
Background: Drug-eluting stents (DES) showed improved efficacy and safety compared with bare-metal stents (BMS), and international guidelines recommend their use as first line treatment. Yet, BMS are still widely used in practice, especially in large
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76b67e8708a6a719851293490ec64870
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2457
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2457
Autor:
Maarten J. Suttorp, Salvatore Brugaletta, Thomas Pilgrim, Lorenz Räber, Bianca Backx, Stephan Windecker, Patrick W. Serruys, Evald Høi Christiansen, Hector M. Garcia-Garcia, Lisette Okkels Jensen, Àngel Cequier-Fillat, Sjoerd H. Hofma, Manel Sabaté, Yoshinobu Onuma, Andrés Iñiguez
Publikováno v:
EuroIntervention, 12(4), 482-489. EuroPCR
Raber, L, Onuma, Y, Brugaletta, S, Garcia-Garcia, H M, Backx, B, Iniguez, A L, Jensen, L O, Cequier-Fillat, A, Pilgrim, T, Christiansen, E H, Hofma, S H, Suttorp, M, Serruys, P W, Sabaté, M & Windecker, S 2016, ' Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction : rationale and design of the randomised TROFI II study ', EuroIntervention, vol. 12, no. 4, pp. 482-489 . https://doi.org/10.4244/eijy15m08_03
Räber, L, Onuma, Y, Brugaletta, S, Garcia-Garcia, H M, Backx, B, Iñiguez, A, Jensen, L O, Cequier-Fillat, À, Pilgrim, T, Christiansen, E H, Hofma, S H, Suttorp, M, Serruys, P W, Sabaté, M & Windecker, S 2015, ' Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction : rationale and design of the randomised TROFI II study ', EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, vol. 11, no. 4 . https://doi.org/10.4244/EIJY15M08_03
Raber, L, Onuma, Y, Brugaletta, S, Garcia-Garcia, H M, Backx, B, Iniguez, A L, Jensen, L O, Cequier-Fillat, A, Pilgrim, T, Christiansen, E H, Hofma, S H, Suttorp, M, Serruys, P W, Sabaté, M & Windecker, S 2016, ' Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction : rationale and design of the randomised TROFI II study ', EuroIntervention, vol. 12, no. 4, pp. 482-489 . https://doi.org/10.4244/eijy15m08_03
Räber, L, Onuma, Y, Brugaletta, S, Garcia-Garcia, H M, Backx, B, Iñiguez, A, Jensen, L O, Cequier-Fillat, À, Pilgrim, T, Christiansen, E H, Hofma, S H, Suttorp, M, Serruys, P W, Sabaté, M & Windecker, S 2015, ' Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction : rationale and design of the randomised TROFI II study ', EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, vol. 11, no. 4 . https://doi.org/10.4244/EIJY15M08_03
AIMS: The Absorb bioresorbable vascular scaffold (Absorb BVS) provides similar clinical outcomes compared with a durable polymer-based everolimus-eluting metallic stent (EES) in stable coronary artery disease patients. ST-elevation myocardial infarct
Autor:
Bianca Backx, Pieter den Heijer, Antonio Serra, Angel Cequier, Manel Sabaté, Patrick W. Serruys, Maurizio Tespili, Nicolás Vázquez, Salvatore Brugaletta, Andrés Iñiguez, Rosana Hernádez-Antolín, Vicente Mainar, Armando Bethencourt, Marco Valgimigli
Publikováno v:
JACC: Cardiovascular Interventions. 7(1):64-71
Objectives This study sought to assess the 2-year outcomes of the population included in the EXAMINATION (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction) trial beyond the 1-year prescription period of
Autor:
Yoshitaka Shiratori, Andrés Iñiguez, Salvatore Brugaletta, Rosana Hernández-Antolín, Vicente Mainar, Armando Bethencourt, Pieter den Heijer, Marco Valgimigli, Bianca Backx, Angel Cequier, Manel Sabaté, Maurizio Tespili, Victoria Martin-Yuste, Nicolás Vázquez, Josep Gomez-Lara, Mónica Masotti, Patrick W. Serruys, Luis Alvarez-Contreras, Antonio Serra
Publikováno v:
International Journal of Cardiology. 168:2632-2636
Background Few data are available about safety of second generation drug eluting stents in an all-comer ST elevation myocardial infarction (STEMI) population. We sought to investigate the predictors and clinical implications of 1-year stent thrombosi
Autor:
Vicente Mainar, Gianluca Campo, Armando Bethencourt, Nicolás Vázquez, Marco Valgimigli, Andrés Iñiguez, Gerrit Anne van Es, Maurizio Tespili, Antonio Serra, Pilar Jiménez-Quevedo, Bianca Backx, Patrick W. Serruys, Angel Cequier, Manel Sabaté, Peter den Heijer, Salvatore Brugaletta
Publikováno v:
LANCET
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Lancet (UK), 387(10016), 357-366. Elsevier Ltd.
Sabaté, Manel; Brugaletta, Salvatore; Cequier, Angel; Iñiguez, Andrés; Serra, Antonio; Jiménez-Quevedo, Pilar; Mainar, Vicente; Campo, Gianluca; Tespili, Maurizio; den Heijer, Peter; Bethencourt, Armando; Vazquez, Nicolás; van Es, Gerrit Anne; Backx, Bianca; Valgimigli, Marco; Serruys, Patrick W (2016). Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial. Lancet, 387(10016), pp. 357-366. Elsevier 10.1016/S0140-6736(15)00548-6
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Lancet (UK), 387(10016), 357-366. Elsevier Ltd.
Sabaté, Manel; Brugaletta, Salvatore; Cequier, Angel; Iñiguez, Andrés; Serra, Antonio; Jiménez-Quevedo, Pilar; Mainar, Vicente; Campo, Gianluca; Tespili, Maurizio; den Heijer, Peter; Bethencourt, Armando; Vazquez, Nicolás; van Es, Gerrit Anne; Backx, Bianca; Valgimigli, Marco; Serruys, Patrick W (2016). Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial. Lancet, 387(10016), pp. 357-366. Elsevier 10.1016/S0140-6736(15)00548-6
Background Data for the safety and efficacy of new-generation drug-eluting stents at long-term follow-up, and specifically in patients with ST-segment elevation myocardial infarction, are scarce. In the EXAMINATION trial, we compared everolimus-eluti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7c347750c7231ba9837fce73d82abd5
http://hdl.handle.net/11392/2372761
http://hdl.handle.net/11392/2372761
Autor:
Matteo Tebaldi, Antonio Silvestro, Rosana Hernández-Antolín, Salvatore Brugaletta, Maurizio Tespili, Victoria Martin-Yuste, Patrick W. Serruys, Manel Sabaté, Fernando Alfonso, José Antonio Baz, Robert-Jan van Geuns, Bianca Backx, Pieter den Heijer, Angel Cequier, Nicolás Vázquez, Joan Antoni Gómez-Hospital, Gerrit Anne van Es, Pascual Bordes, Mónica Masotti, Antonio Serra, Vicente Mainar, Armando Bethencourt, Marco Valgimigli, Andrés Iñiguez
Publikováno v:
Lancet (UK), 380(9852), 1482-1490. Elsevier Ltd.
Summary Background Everolimus-eluting stent (EES) reduces the risk of restenosis in elective percutaneous coronary intervention. However, the use of drug-eluting stent in patients with ST-segment elevation myocardial infarction (STEMI) is still contr
Autor:
Johannes A. Schaar, Patrick W. Serruys, Frits Mastik, Andrew Zalewski, Nico R. Mollet, Marco Valgimigli, Filippo Cademartiri, Georgios Sianos, Eugene P. McFadden, Marie-Angèle Morel, Bianca Backx, Gerrit-Anne van Es, Pim J. de Feyter, Carlos Van Mieghem, Sebastiaan de Winter, Nico Bruining, Dick Goedhart, Gaston A. Rodriguez Granillo, Anton F. W. van der Steen, Willem J. van der Giessen
Publikováno v:
Journal of the American College of Cardiology, 47(6), 1134-1142. Elsevier Inc.
Objectives Our purpose was to assess noninvasive imaging in detection of subclinical atherosclerosis and to examine novel invasive modalities to describe prevalence and temporal changes in putative characteristics of “high-risk” plaques. Backgrou
Autor:
Clemens Disco, Adib D Jatene, Robert S. Bonser, Lex A. van Herwerden, Johannes J. R. M. Bonnier, J. Eduardo Sousa, Patrick W. Serruys, Jacques P.M.A. Schönberger, Nigel Buller, Paul G. Hugenholtz, Bianca Backx, Felix Unger, Brian G. Firth, Andrew T.L. Ong
Publikováno v:
Journal of the American College of Cardiology. 46:575-581
Objectives The long-term (five-year) comparative results of treatment of multivessel coronary artery disease with stenting or coronary artery bypass grafting (CABG) is at present unknown. Background The Arterial Revascularization Therapies Study (ART
Autor:
Keith D. Dawkins, Wolfgang Rutsch, Victor Legrand, Bianca Backx, Marco Bressers, Harry Suryapranata, Phillipe Materne, Benno J. Rensing, Michael Cobaugh, William Wijns, Angelo Anzuini, David P. Foley, Patrick W. Serruys, Martin Jan Suttorp, Edouard Benit, Antonio Colombo, Arijan van den Bos
Publikováno v:
Journal of the American College of Cardiology. 39(3):393-399
Objectives We sought to investigate the clinical benefit of additional stent implantation after achieving an optimal result of balloon angioplasty (BA) in long coronary lesions (>20 mm). Background Long coronary lesions are associated with increased